James Eldridge | Director, Global Drug Safety
Y-mAbs

I am a pharmacovigilance leader with a strong background in global PV regulations and safety surveillance. In my current role as Director, Global Safety Surveillance at Y-mAbs Therapeutics, Inc., I am responsible for managing global safety surveillance for both developmental and marketed products. This includes an approved biological product indicated for pediatric neuroblastoma and the development of multiple theranostic radiopharmaceuticals for various indications in rare disease oncology. My expertise encompasses a broad background in the many areas within pharmacovigilance. Before joining Y-mAbs, I held senior positions at ALK-Abello, Inc., including Senior Manager, Head of Global Pharmacovigilance North America, where I managed PV teams and ensured regulatory compliance.